Difference between revisions of "Prostate gland"

Jump to navigation Jump to search
552 bytes added ,  19:00, 23 January 2013
Line 428: Line 428:


===Microscopic===
===Microscopic===
Features:
Features:<ref name=Ref_Amin3-56>{{Ref Amin|3-56}}</ref><ref name=pmid2002502>{{Cite journal  | last1 = Chin | first1 = AI. | last2 = Dave | first2 = DS. | last3 = Rajfer | first3 = J. | title = Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary? | journal = Rev Urol | volume = 9 | issue = 3 | pages = 124-31 | month =  | year = 2007 | doi =  | PMID = 17934569 | PMC = 2002502 }}</ref>
*Architectural changes - see below, usually tufting.
*Medium to large glands with architectural changes - see ''HGPIN architecture'' below.
**Described as "epithelial hyperplasia".
*Diagnosed on basis of nuclear changes.
*Diagnosed on basis of nuclear changes.
**Hyperchromatic nuclei - '''key (low power) feature'''.
**Hyperchromatic nuclei - '''key (low power) feature'''.
**Nucleoli present - '''key (high power) feature'''.
**Nucleoli present - '''key (high power) feature'''.
**Often increased N/C ratio.
**Often increased NC ratio.
**Nuclear enlargement.
**Nuclear enlargement.
*Usually epithelial hyperplasia.


Notes:
Notes:
*Nucleoli should be visible with the 20x objective.
*Nucleoli should be visible with the 20x objective.
**If one uses the 40x objective... one over calls.
**If one uses the 40x objective... one over calls.
**Some pathologists require nucleoli to be present in >= 10% of cells in a gland to call it HGPIN.
*May need IHC for cancer versus HGPIN.
*May need IHC for cancer versus HGPIN.


48,830

edits

Navigation menu